• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

Formulary Digital Edition, June 2010

Article

Pulmonary arterial hypertension: Bridging the gap between efficacy, quality of life, and cost-effectiveness; Lorcaserin: A novel, selective 5-HT2C-receptor agonist for the treatment of obesity; Vaccine agents in late-stage development.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.